Industries Market Research Reports

Subscribe to RSS Feed
  1. 30 Nov 2021  |  Global  |  Technology Research

    Targeted Immunotherapy in Oncology

    Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications

    This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

    $4,950.00
  2. 24 Nov 2021  |  Global  |  Technology Research

    Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies

    Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities

    The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

    $4,950.00
  3. 22 Nov 2021  |  Global  |  Technology Research

    Technological Advances in RNA Stabilization & Delivery

    LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years

    RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

    $4,950.00
  4. 17 Nov 2021  |  Global  |  Market Research

    Global Pharmaceutical Packaging Growth Opportunities

    The Growing Pipeline of Temperature-sensitive Biologics Products and Healthcare Stakeholders’ Higher Stake in Patient Health Outcomes will Drive Investments

    The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...

    $2,450.00
  5. 23 Jun 2021  |  Global  |  Frost Radar

    Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

    A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

    Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

    $4,950.00
  6. 13 May 2021  |  Global  |  Market Research

    Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market

    Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors

    Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...

    $4,950.00
  7. 17 Dec 2019  |  Global  |  Technology Research

    Emerging Microbiome Technologies for Applications in Skin Care

    Microbiome-based Innovations Transforming the Personal Care Landscape

    Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...

    $4,950.00
  8. 26 Sep 2019  |  Global  |  Market Research

    Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022

    Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry

    Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

    $4,950.00
  9. 20 Sep 2019  |  Global  |  Technology Research

    Technological Advances in Biobetter and Biosimilar Platforms

    Therapeutic Outcomes Optimization

    Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

    $4,950.00
  10. 25 Jun 2019  |  Global  |  Technology Research

    Technologies Transforming the Biomanufacturing Landscape

    Translating Technology Innovation to Market Competitiveness

    Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

    $4,950.00